Navigation Links
Lumena Pharmaceuticals Receives Orphan Drug Designation from US Food & Drug Administration for LUM001 in Four Rare Liver Diseases
Date:9/26/2013

nt therapeutic options for cholestatic liver diseases are of limited efficacy, and surgical approaches to reducing bile acid levels to manage disease symptoms can be disfiguring and prone to complications. The only remaining option for many patients is liver transplant." 

LUM001 has been studied in more than 1,400 patients in 12 different clinical studies. The company also announced today in a separate announcement the initiation of a Phase II study of LUM001 in children with ALGS. The company will also soon be initiating a Phase II study in adult patients with PBC. Later this year, Lumena plans to initiate a Phase II study of LUM001 in pediatric patients with PFIC, and a Phase II study in adults with PSC.

Under the Orphan Drug Act, the U.S. FDA may grant Orphan Drug Designation to a drug intended to treat rare diseases, generally those which affect fewer than 200,000 individuals in the country. Lumena is also pursuing Orphan Drug Designation for LUM001 in all four indications with the European Medicines Agency.

About Alagille Syndrome

ALGS is a rare genetic disorder that can affect the liver, heart, and other parts of the body. Approximately one in every 70,000 children is born with ALGS. In patients with ALGS the bile ducts are abnormally narrow, malformed and reduced in number. This prevents normal bile flow from the liver into the small intestine. As a result, bile builds up in the liver, causing damage that prevents the liver from working properly. ALGS is characterized by elevated bile acids and severe itching, which is generally the most debilitating symptom afflicting children with this liver disease. Treatment with anti-pruritics (anti-itching drugs) typically provides only modest relief. Procedures that remove bile from the circulation can lower serum bile acids, reducing itch and improving liver function in some patients, but tend to be invasive in nature.

About Progre
'/>"/>

SOURCE Lumena Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lumena Pharmaceuticals Launches Global Clinical Program to Evaluate Safety and Efficacy of LUM001 in Children with Alagille Syndrome
2. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
3. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
4. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
5. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
6. Icahn Issues Statement Regarding Amylin Pharmaceuticals
7. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
8. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
9. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
10. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
11. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... CARLSBAD, Calif. , July 10, 2014 /PRNewswire/ ... products and services, has launched the FreeRunner™ knee ... runners, who suffer from patella mal-tracking return to ... anatomy differently than other braces, providing support when ... move normally when they don,t. Patellofemoral ...
(Date:7/10/2014)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... sale to Galderma of all rights to Restylane, Perlane, ... for $1.4 billion in cash, pursuant to the previously ... acquisition of Galderma. "We are pleased ... company that is firmly committed to the aesthetic dermatology ...
(Date:7/10/2014)... -- Decision Resources Group finds that over half of ... Drug Administration,s (FDA) approval of Vifor Fresenius Medical Care ... by the FDA in November 2013 for the treatment ... dialysis. Other key findings from the report ... : , Bundling: Based ...
Breaking Medicine Technology:Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3
... 2011 Researchers presented data demonstrating increased specificity ...  MRI for the detection of breast cancer at ... National Interdisciplinary Breast Center Conference held March 12 ... poster presentation, titled Pre-Surgical Detection of Malignancies ...
... Varian Medical Systems (NYSE: VAR ) announced ... fiscal year 2011 following the close of regular trading on ... by a teleconference available to all interested parties at 2:00 ... conference call webcast will be available on the company website ...
Cached Medicine Technology:Researchers Present Key Findings Comparing PEM to MRI for Identification of Contralateral Breast Cancer at the National Consortium of Breast Centers (NCBC) Conference 2Varian Medical Systems Schedules Second Quarter FY2011 News Release and Conference Call 2
(Date:7/11/2014)... 11, 2014 Netmail, ... with its unique Netmail Platform, today announced that ... Conference (WPC), which will be held in Washington’s ... 2014. During the show, Netmail will officially launch ... solution that consolidates email security, archiving, encryption, eDiscovery, ...
(Date:7/11/2014)... July 11, 2014 Based in Pearland, ... to residents of Brazoria County and surrounding counties. Recently, ... clinic is now accessible from Northbound Highway 288 and ... center where patients can get low-cost urgent care of ... from rare, finding places that can match the quality ...
(Date:7/10/2014)... July 11, 2014 The Capital Institute ... performed the first procedure in a clinical trial that ... in the leg. , During the procedure, done at ... an endovascular neurosurgeon, threaded a tiny catheter through the ... body and neck and into the brain. Once the ...
(Date:7/10/2014)... 2014 More than 200 experts on ... urban street violence, will attend the 21st World Meeting ... (ISRA) at the Loews Atlanta Hotel, July 15-19. ... prestigious world meeting, which is held every other year ... bringing together leading scholars from more than 20 different ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 Ticketability.com has a ... and now Paul McCartney tickets for San Diego are being ... San Diego since 1976, and the newly added September 28 ... fans. , Click Here to view the selection ... for Petco Park will become available to the general public ...
Breaking Medicine News(10 mins):Health News:Netmail Heads to Washington, D.C. to Demonstrate New Release of Netmail 5.3 at WPC 2014 July 13-17, 2014 2Health News:Netmail Heads to Washington, D.C. to Demonstrate New Release of Netmail 5.3 at WPC 2014 July 13-17, 2014 3Health News:Prime Urgent Care Announces New Access to the Clinic, Available from Northbound Highway 288 2Health News:New Trial Delivers Chemotherapy to Brain Tumor Through Artery in Leg 2Health News:New Trial Delivers Chemotherapy to Brain Tumor Through Artery in Leg 3Health News:Georgia State Hosts National Conference On Aggression 2Health News:Georgia State Hosts National Conference On Aggression 3Health News:Georgia State Hosts National Conference On Aggression 4Health News:Paul McCartney Tickets for San Diego: Ticketability.com Announces Discounted Tickets for McCartney’s Tour Stop at Petco Park on September 28 2
... the Vrije University in Amsterdam in collaboration with the University of ... , Usually in case of throat cancer the larynx or ... removed. , The patients after this surgery find it ... valve is implanted in-between the windpipe and oesophagus. ,But ...
... If smoking were to be banned by the Government ... home will be affected by passive smoking. Children suffer ... passive smoking. The economists belonging to the University College ... anti-smoking campaigners. ,Smokers will be encouraged ...
... Center for Health Studies of Seattle has revealed that chronic ... as 101 adults who suffer from back pain were assessed ... minutes every week displayed greater progress when compared to those ... ,Yoga has also been found to be more useful than ...
... Angeles County health officials which will facilitate the sending of ... diseases. The site called, inSPOTLA.org is meant // to check ... site is targeted at people seeking casual sex on line. ... in 2004 has resulted in as many as 20,000 e-mails. ...
... A new report has revealed that wild thrashing during ... of Parkinson's disease. Professor Claudia Trenkwalder said that disruptions ... could be a signal to approaching Parkinson's disease, according ... muscles are normally relaxed and disconnected from motor controls ...
... The cervical cancer vaccine, Cervarix, appears to work best in ... GlaxoSmithKline (GSK). ,The vaccine targets the human papilloma virus, ... it works pretty well in the 15-25 age group as ... high as that found in this group. This appears to ...
Cached Medicine News:
... a completely automated instrument that offers Rapid ... 6 hour same day turnaround), random or ... It is used for bacterial and yeast ... and has a complete data management system. ...
IDS Rapid One, a microbial identification system....
The Cogent Microbial Luminescence System (MLS) is a superior Rapid microbial detection system for UHT product screening combining proven technology of ATP-bioluminescence with unsurpassed hardware in...
... SkanWasher 300 is an ... designed to give reliable, ... cross-contamination between wells, and ... to plate. The washer ...
Medicine Products: